Fuai A. Lu
Baotou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Telitacicept in patients with active systemic lupus erythematosus: results of a phase 2b, randomised, double-blind, placebo-controlled trial.
Journal: Annals of the rheumatic diseases
Published: August 15, 2023
The silencing of lnc-NONHSAT071210 suppresses the proliferation, fibrosis, migration, and invasion of TGFβ1-treated lung epithelial cells.
Journal: Annals of translational medicine
Published: October 09, 2022
Comparison of short interval and low dose (SILD) with high dose of cyclophosphamide in the susceptibility to infection in SLE: a multicentrereal-world study.
Journal: Lupus science & medicine
Published: July 10, 2022
Fine Comparison of the Efficacy and Safety Between GB242 and Infliximab in Patients with Rheumatoid Arthritis: A Phase III Study.
Journal: Rheumatology and therapy
Published: July 28, 2021
Clinical characteristics and related factors of systemic lupus erythematosus with interstitial pneumonia
Journal: Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences
Published: April 21, 2021
BTB and CNC homology 1 inhibition ameliorates fibrosis and inflammation via blocking ERK pathway in pulmonary fibrosis.
Journal: Experimental lung research
Published: November 26, 2020
Pirfenidone attenuates bleomycin-induced pulmonary fibrosis in mice by regulating Nrf2/Bach1 equilibrium.
Journal: BMC pulmonary medicine
Published: July 17, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026